Uğur Eray

Uğur Eray

Auto-generated profile, based on publicly available information

Uğur Eray

Kars Harakani Devlet Hastanesi

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2022 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
UEUğur Eray
Uğur Eray
BAbasar ayribas
basar ayribas
ÖÇÖmer Furkan Çağlar
Ömer Furkan Çağlar
THTurgut Hacioğlu
Turgut Hacioğlu
FAFatih Alibeyoglu
Fatih Alibeyoglu
Aim: Although primarily known as a respiratory system pathology, COVID-19 may cause various systems and cause serious complications including neuropsychiatric problems. These complications may be formulized as post-COVID syndrome. The current study aims to investigate prolonged cognitive, somatic and psychiatric effects of COVID-19. Material and Method: A total number of 120 COVID-19 survivors were compared with 120 health controls in means of three measures, which are Cognitive Failures Questionnaire (CFQ), Body Sensations Questionnaire (BSQ), Hospital Anxiety and Depression Scale (HADS) to assess cognitive difficulties, body perceptions and anxiety/depression. Results: Our findings show that COVID-19 survivors have reported significantly more cognitive difficulties, increased body sensations and higher levels of anxiety. The groups did not differ in means of depression scores. Further, the measures were significantly correlated with each other. Conclusion: This study reveal that COVID-19 survivors suffer from significant cognitive deficits in everyday activities, are significantly more sensitive to various body sensations and have increased anxiety levels. In discordance with the current literature, our findings showed that COVID-19 patients are not more depressed than healthy subjects. In summary, the current study showed that various neuropsychiatric complications may be an important part of prolonged effects of COVID-19.

24 May 2024 in Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
UEUğur Eray
Uğur Eray
Corticosteroids are used in the treatment of numerous diseases, primarily in the treatment of autoimmune diseases. They have various side-effects. Although the pathophysiology of psychiatric side-effects have not clearly been revealed, the various risk factors leading to these have been defined. In the treatment of psychiatric symptoms which emerge after steroid treatments, it is firstly advised to discontinue the use of the steroid and initiate the use of an antipsychotic medicine together with a mood regulator or single-handedly. It is aimed at discussing the manic attack which took place after corticosteroid use in our patient diagnosed with pemphigus vulgaris, the risk factors leading to this situation and the course of the disease only with olanzapine.